Image

Global Genomics Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
  • Healthcare
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Genomics Market, By Deliverables (Product, Services), Technology (Sequencing, Microarray, PCR, Nucleic Acid Extraction, Purification), Process (Sequencing, Library Preparation, Data Analysis), Application (Epigenomics, Functional, Biomarker Discovery, Pathway Analysis), End-User (Government and Academic Institutes, Clinical Research, Biotechnology and Pharmaceutical Companies, Hospitals and Clinics, Others) – Industry Trends and Forecast to 2029

Genomics Market

Global Genomics Market Analysis and Size

Over the years, genomics has had a significant impact on health care. Medicine and biomedical sciences are undergoing a profound transformation, fueled by the genomics revolution. Genomics is the study of deciphering, interpreting, and applying DNA code to real-world problems. The most transformative technology of the twenty-first century is genomics. Therefore, owing to the rise in government funding to support genomics projects will further aid the market expansion over the forecasted period.

  • Global genomics market was valued at USD 27.12 billion in 2021 and is expected to reach USD 112.80 billion by 2029, registering a CAGR of 19.5% during the forecast period of 2022-2029. The "PCR" accounts for the largest technology segment in the genomics market within the forecasted period owing to the lower cost of DNA amplification using PCR, the surge in research in the field of genomics, and other technological advancements. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Global Genomics Market Definition

The study of genomes and their interactions with various stimuli, which is the focus of development activities, is referred to as genomics. One of the reasons for the rise in technologies that provide a better understanding of genomes and their interactions is genomics.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Deliverables (Product, Services), Technology (Sequencing, Microarray, PCR, Nucleic Acid Extraction, Purification), Process (Sequencing, Library Preparation, Data Analysis), Application (Epigenomics, Functional, Biomarker Discovery, Pathway Analysis), End-User (Government and Academic Institutes, Clinical Research, Biotechnology and Pharmaceutical Companies, Hospitals and Clinics, Others)

Countries Covered

U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E, Egypt, Israel, Rest of Middle East and Africa

Market Players Covered

Illumina, Inc. (U.S.), Thermo Fisher Scientific (U.S.), QIAGEN (Netherlands), Agilent Technologies, Inc. (U.S.), McKesson Corporation (U.S), R1 RCM Inc., (U.S), HCL Technologies Limited (India), Atos S.E., (France), Allscripts Healthcare, LLC, (U.S), Accenture, (Ireland), Cognizant, (U.S), Siemens, (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), and BGI (China)

Genomics Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

Drivers

  • Growing Incidence of Cancer

The surge in incidence of cancer and increasing applications of next-generation sequencing in cancer research is the most significant factor driving the growth for this market.

In addition to this, the rise in the government funding to support genomics projects coupled with the massive changes in technology that allowed researchers to interrogate larger pieces of the human genome across the globe is expected to fuel market growth. Moreover, the usage of multiomic-based approaches and genome-wide association studies (GWAS) for discovering biological networks and common variants underlying host-pathogen interactions, and utilization of genomics for even deciphering COVID-19 complications, resistance, and susceptibility also cushion the market's growth within the forecasted period. The advent of genetic susceptibility and severity to SARS-CoV-2 infection by combining research efforts using existing genetic databases is also projected to cushion the market's growth. Moreover, the use of genomics concepts in synthetic biology, study gene sequences of plants and organisms, and the use of genomics in specialized/personalized medicine are estimated to generate lucrative opportunities for the market.

Restraints/Challenges Global Genomics Market

  • Requirement of Trained Professionals

The genomics require the skilled professionals. The lack of trained professionals is expected to obstruct market growth.

Furthermore, the high cost associated with the genomic equipment and issues in securing the storage of large volumes of sequenced data are projected to challenge the genomics market in 2022-2029.

This genomics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the genomics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Post Covid-19 Impact on Genomics Market

The genomics market was positively impacted by the outbreak of COVID-19. The market saw an accelerated growth owing to the wide range of genomic products used in COVID-19 research to better understand the coronavirus. Researchers attempted to address genetic severity and susceptibility to SARS-CoV-2 infection using existing genetic databases. Genome-wide association studies (GWAS) and multiomic-based approaches have been used to uncover the common variants underlying host-pathogen interactions and biological networks.

Furthermore, data from genomes, such as ABO blood groups and polygenic risk scores (PRS), could be used to decode COVID-19 susceptibility, complications, and resistance. Biobanks that link genomic data to electronic health records can also be used to investigate the impact of genomic factors on the clinical course of COVID-19 patients.

Recent Developments

  • According to Helix, in August 2020, The Helix COVID-19 NGS Test has received Emergency Use Authorization from the U.S. Food and Drug Administration. The test is an amplicon-based next-generation sequencing test designed to detect nucleic acid from SARS-CoV-2 suspects in a qualitative manner. These product approvals are likely to significantly impact the market under investigation.

Global Genomics Market Scope

The genomics market is segmented on the basis of deliverables, technology, process, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Deliverables

  • Product
  • Services

On the basis of deliverables, the genomics market is segmented into product and services.

Technology

  • Sequencing
  • Microarray
  • PCR
  • Nucleic Acid Extraction
  • Purification

On the basis of technology, the genomics market is segmented into sequencing, microarray, PCR, nucleic acid extraction and purification. PCR will hold the largest market share in the forecasted period owing to the lower cost of DNA amplification using PCR, the surge in research in the field of genomics and other technological advancements in this segment.

Process

  • Sequencing
  • Library Preparation
  • Data Analysis

On the basis of process, the genomics market is segmented into sequencing, library preparation and data analysis.

Application

  • Epigenomics
  • Functional
  • Biomarker Discovery
  • Pathway Analysis

On the basis of application, the genomics market is segmented into epigenomics, functional, biomarker discovery and pathway analysis. Epigenomics are further segmented into chromatin immunoprecipitation, bisulfite sequencing, methylated DNA immunoprecipitation, chromatin accessibility assays, high-resolution melt and microarray analysis. Functional is further segmented into real-time PCR, transfection, RNA interference, SNP analysis and mutational analysis. Biomarker discovery is further segmented into real-time PCR, mass spectrometry, microarray analysis, bioinformatics, statistical analysis and DNA sequencing. Pathway analysis is further segmented into microarray analysis, bead-based analysis, real-time PCR, proteomics tools and others.

End-User

  • Government and Academic Institutes
  • Clinical Research
  • Biotechnology and Pharmaceutical Companies
  • Hospitals and Clinics
  • Others

On the basis of end-user, the genomics market is bifurcated into government and academic institutes, clinical research, biotechnology and pharmaceutical companies, hospitals and clinics and others.

Genomics Market Regional Analysis/Insights

The genomics market is analyzed and market size insights and trends are provided by country, deliverables, technology, process, application and end-user as referenced above.

The countries covered in the genomics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the genomics market because of the U.S.'s genomics research grants and funds and support from key industrial players and increasing incidences of cancer within the region.

Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increased focus of the increasing genetic research and development activities and government on encouraging research in the field of genomics and drastically reduced mass scale genetic testing costs within the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The genomics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for genomics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the genomics market. The data is available for historic period 2010-2020.

Competitive Landscape and Genomics Market Share Analysis

The genomics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to genomics market.

Some of the major players operating in the genomics market are Illumina, Inc. (U.S.), Thermo Fisher Scientific (U.S.), QIAGEN (Netherlands), Agilent Technologies, Inc. (U.S.), McKesson Corporation (U.S), R1 RCM Inc., (U.S), HCL Technologies Limited (India), Atos S.E., (France), Allscripts Healthcare, LLC, (U.S), Accenture, (Ireland), Cognizant, (U.S), Siemens, (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), and BGI (China) among others.

Research Methodology : Global Genomics Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-genomics-market


SKU-
Why Choose Us


Frequently Asked Questions

The Genomics Market is Expected to Show a Value of USD 112.80 billion by 2029.
The Genomics Market is Estimated to Register a CAGR of 19.5% Within the Forecast Period of 2022 to 2029.
The Factor Such as Increasing Applications of Next-Generation Sequencing in Cancer Research, Advent Of Genetic Susceptibility and Severity to SARS-Cov-2 Infection by Combining Research Efforts Using Existing Genetic Databases and Rise in the Government Funding to Support Genomics Projects are the Major Drivers for the Genomics Market.
The Major Companies Operating in the Genomics Market are Illumina, Inc. (U.S.), Thermo Fisher Scientific (U.S.), QIAGEN (Netherlands), Agilent Technologies, Inc. (U.S.) and McKesson Corporation (U.S).
The Countries Covered in the Genomics Market Report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.